20th Annual School of Breast Oncology®

20th Annual School of Breast Oncology® is organized by Physicians' Education Resource, LLC (PER) and will be held from Nov 03 - 05, 2022 at Emory Conference Center Hotel, Atlanta, Georgia, United States of America.

Intended Audience:
This educational program is directed toward medical, radiation, and surgical oncologists whose primary practice focus is breast cancer and who intend to reinforce their knowledge base and expand their expertise in breast cancer diagnosis, treatment, and management. Participants will be primarily oncologists or fellows-in-training whose practice requires mastery and a critical understanding of the fundamental principles, pivotal published studies, and emerging information on the pathogenesis and management of breast cancer.

Overview:
As more oncologists focus their clinical practices on the treatment of breast cancer, specialized education continues to be ever-important. Now celebrating its 20th anniversary, the School of Breast Oncology®, continues to help clinicians improve their patient care with a curriculum-based program that focuses exclusively on breast cancer clinical management. This 3-day, highly interactive program will provide a comprehensive review of data on the most important aspects of breast cancer biology, diagnostics, prevention, and treatment, and include lectures and panel discussions with leading clinical investigators emphasizing how best to incorporate the information into clinical practice.

Learning Objectives:
The learning objectives of this program are:
• Review breast cancer biology, molecular subtyping, staging, and prognostic and/or predictive biomarkers, in order to better individualize therapy and counsel patients regarding conventional and investigational treatment options
• Integrate genomic and molecular biomarkers, and gene expression assays, into treatment planning to optimize outcomes for patients with breast cancer
• Discuss the application of current and evolving imaging options for diagnosing, staging, and monitoring breast cancer
• Incorporate current guidelines and evolving evidence regarding local treatment options, including advances in surgery and radiation therapy
• Take into consideration efficacy and safety data, expert guidelines, patient characteristics and comorbidities, and genomic and/or molecular tumor information to individualize the selection of systemic therapies for patients with early-stage or advanced/metastatic disease
• Evaluate emerging clinical data and evolving strategies for the treatment of breast cancer, and apply clinical trial data appropriately to optimize outcomes for individual patients
• Facilitate awareness of clinical trial opportunities based on knowledge of emerging approaches and variances in care in the field of breast cancer management

Benefits of Attending:
• Explore how to better integrate biomarkers, molecular assays, and other risk-assessment tools into your treatment decision-making algorithms to optimize patient outcomes 
• Learn to apply current and emerging imaging techniques for the diagnosis, staging, and management of breast cancer
• Review current guidelines and evolving evidence on local treatment options, including new approaches in surgery and radiation therapy
• Learn how best to individualize the selection of systemic therapies for patients with early-stage or advanced/metastatic disease by considering patient-, disease-, and provider-related factors
• Acquire expert insights into the use of supportive care strategies to prevent and manage treatment-related toxicities